262 related articles for article (PubMed ID: 17634845)
1. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
3. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
Becker W; Börner W; Reiners C
Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
[TBL] [Abstract][Full Text] [Related]
5. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
6. Early Phase I Study of a
Xing Y; Chand G; Liu C; Cook GJR; O'Doherty J; Zhao L; Wong NCL; Meszaros LK; Ting HH; Zhao J
J Nucl Med; 2019 Sep; 60(9):1213-1220. PubMed ID: 30796165
[TBL] [Abstract][Full Text] [Related]
7. Imaging α
Cook GJR; Azad GK; Taylor BP; Lee E; Morrison MS; Hughes S; Morris S; Rudman S; Chowdhury S; Goh V
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):898-903. PubMed ID: 29396636
[TBL] [Abstract][Full Text] [Related]
8. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
[TBL] [Abstract][Full Text] [Related]
10. Altered Biodistribution on 99m Tc-Dimercaptosuccinic Acid Renal Scan.
Mercer MK; Parisi MT; Revels JW; Blacklock L; Elojeimy S
Clin Nucl Med; 2023 Apr; 48(4):e170-e172. PubMed ID: 36630966
[TBL] [Abstract][Full Text] [Related]
11. Is ECT imaging with Tc(V)-99m dimercaptosuccinic acid useful to detect lung metastases of osteosarcoma?
Ohta H; Ishii M; Yoshizumi M; Endo K; Fujita T; Nakajima T; Sakahara H; Torizuka K; Kotoura Y; Yokoyama A
Clin Nucl Med; 1985 Jan; 10(1):13-5. PubMed ID: 2983922
[TBL] [Abstract][Full Text] [Related]
12. Interrater Reliability of
Einarsdóttir HS; Berg RMG; Borgwardt L
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33348530
[TBL] [Abstract][Full Text] [Related]
13. [
Valind K; Minarik D; Garpered S; Persson E; Jögi J; Trägårdh E
Eur J Hybrid Imaging; 2023 Nov; 7(1):25. PubMed ID: 37996712
[TBL] [Abstract][Full Text] [Related]
14. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody.
Vansant JP; Johnson DH; O'Donnell DM; Stewart JR; Sonin AH; McCook BM; Powers TA; Salk DJ; Frist WH; Sandler MP
Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between normal and abnormal kidneys using
Lin C; Chang YC; Chiu HY; Cheng CH; Huang HM
Clin Radiol; 2023 Aug; 78(8):584-589. PubMed ID: 37244824
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m(V) DMSA uptake in cardiac amyloidosis.
Ohta H; Okada T; Furukawa Y; Yamamoto K; Miyaki Y; Shizuki K; Kotoura H; Endo K; Konishi J; Ohshima C
Clin Nucl Med; 1991 Sep; 16(9):673-5. PubMed ID: 1657486
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
[TBL] [Abstract][Full Text] [Related]
18. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate.
Lyons KP; Milne N; Karlsberg RP; Olson HG; Kuperus J
Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m(v) dimercaptosuccinic acid planar scintigraphy in head and neck cancer: clinical, scintigraphic and radiological study.
Watkinson JC; Todd CE; Lazarus CR; Maisey MN; Clarke SE
J Laryngol Otol; 1990 Oct; 104(10):783-9. PubMed ID: 2174074
[TBL] [Abstract][Full Text] [Related]
20. 99mTc(V)-DMSA and 99mTc-MDP uptake and no 67Ga-citrate uptake in a case of primary pulmonary leiomyosarcoma.
Ohta H; Komibuchi T; Nishiyama H; Shizuki K; Miyaki Y
Ann Nucl Med; 1992 Aug; 6(3):191-3. PubMed ID: 1327043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
